2 Top Marijuana Stocks To Watch This Upcoming Week
Many marijuana stock investors are waiting to see how some companies will report earnings. Although some investors are not trading from a fundamental standpoint the growth of the cannabis industry is looking strong. There has been an increase in legal states and some new states that could soon go legal in 2022. Some companies even in a volatile market have done well as a business. With the continued growth of the industry, the anticipation of what companies will report could help to see some upward trading. There are a handful of people who feel that the volatile decline in most cannabis stocks has created more caution.
But for others, it was meant to adapt to the sector and learn how to better trade marijuana stocks. Market volatility for the cannabis sector can be aggressive making it tough for all shareholders to take profits. In recent trading, most marijuana stocks have had very little sustainability with any kind of recovery. Nevertheless, those who were able to keep up with the shift have had better luck in taking profits. If you are looking to invest in marijuana stocks make sure you learn about the sector. As well find companies that you feel will provide the most value both short and long term. The companies below are several options to keep on your radar this week.
Top Marijuana Stocks In 2022
Greenlane Holdings, Inc.
Greenlane Holdings, Inc. develops and distributes cannabis accessories, child-resistant packaging, vape solutions, and lifestyle products in the United States, Canada, and Europe. It operates through two segments, Consumer Goods and Industrial Goods. In recent news, the company announced the board’s approval of the reverse stock split ratio. As well as the effectiveness date.
The reverse split is primarily intended to bring Greenlane into compliance with the minimum bid price requirement for maintaining its listing on the Nasdaq. The new CUSIP number for the Class A common stock following the reverse split will be 395330202.
Cresco Labs Inc.
Cresco Labs Inc. together with its subsidiaries cultivates, manufactures, and sells retail and medical cannabis products in the United States. Back on August 1st, the company announced it would hold its Q2 earnings call on August 17th. The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
As well back on July 15th, the company gained approval from the Supreme court of British Columbia to work with Columbia Care Inc. The final order follows on achieving overwhelming shareholder approval for the business combination at the special meeting of shareholders of the Company held on July 8, 2022.
Words From The Company 7/15/22
“This final order is yet another milestone achieved towards creating the industry leader in cannabis, and we’re pleased with the forward progress in completing the transformational combination with Cresco,” said Nicholas Vita, Co-Founder, CEO of Columbia Care. “With this final order in hand, we are now focused on continued momentum in the divestiture process and state-level approvals. We look forward to providing additional details in the coming months.”